Analyst Recommendations

UBS analyst issues BUY recommendation for SYY on January 28, 2026 01:18PM ET. The previous analyst recommendation was Buy.SYY was trading at $83.92 at issue of the analyst...

January 28, 2026   SYY -0.38%

UBS analyst issues NEUTRAL recommendation for KMB on January 28, 2026 01:20PM ET. The previous analyst recommendation was Neutral.KMB was trading at $100.64 at issue of the analyst...

January 28, 2026   KMB 0.16%

Jefferies analyst issues BUY recommendation for SYY on January 28, 2026 01:26PM ET. The previous analyst recommendation was Buy.SYY was trading at $83.92 at issue of the analyst...

January 28, 2026   SYY -0.38%

UBS analyst issues NEUTRAL recommendation for NUE on January 28, 2026 11:16AM ET. The previous analyst recommendation was Buy.NUE was trading at $173.58 at issue of the analyst...

January 28, 2026   NUE 0.09%

Citigroup analyst issues NEUTRAL recommendation for SYY on January 28, 2026 11:34AM ET. The previous analyst recommendation was Neutral.SYY was trading at $83.92 at issue of the analyst...

January 28, 2026   SYY -0.38%

Piper Sandler analyst issues NEUTRAL recommendation for SYY on January 28, 2026 11:46AM ET. The previous analyst recommendation was Neutral.SYY was trading at $83.92 at issue of the...

January 28, 2026   SYY -0.38%

Piper Sandler analyst issues NEUTRAL recommendation for BDX on January 28, 2026 11:51AM ET. The previous analyst recommendation was Neutral.BDX was trading at $203.4 at issue of the...

January 28, 2026   BDX 0.35%

Barclays analyst issues OVERWEIGHT recommendation for SYY on January 28, 2026 10:47AM ET. The previous analyst recommendation was Overweight.SYY was trading at $83.92 at issue of the analyst...

January 28, 2026   SYY -0.38%

Morgan Stanley analyst issues OVERWEIGHT recommendation for JNJ on January 28, 2026 06:02AM ET. The previous analyst recommendation was Underperform.JNJ was trading at $224.44 at issue of the...

January 28, 2026   JNJ 0.16%

Oppenheimer analyst issues PERFORM recommendation for EMR on January 27, 2026 09:58AM ET. The previous analyst recommendation was Outperform.EMR was trading at $149.13 at issue of the analyst...

January 27, 2026   EMR -0.66%